Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 10 Health Care Startup Investors in Latvia in January 2026

Last updated: Jan 2026 A list of 10 angel investors and VC (Venture Capital) funds that invest in Health care startups based in Latvia. We rank investors based on the number of investments they made in Health care companies from Latvia. We update this investor list every month.

Top 10 Health Care Startup Investors in Latvia in January 2026

Investor	Health Care Latvia investments
FlyCap	3
Imprimatur Capital Fund Management	3
ZGI Capital	2
SOSV	2
Abingworth	2
Qiming Venture Partners USA	2
Roche Venture Fund	1
TSVC	1
Citadel	1
Alexandria Venture Investments	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

FlyCap AIF is a Venture Capital Fund of total size of 15.75 MEUR. The Fund provides growth capital for Latvia based SME’s in a form of investments in equity and mezzanine capital.

Investment focus

Health Care, Consumer Goods, Medical
Funding Round, Seed, Debt Financing
Latvia, Estonia, The Netherlands

Portfolio highlights

Tapcore — Tapcore is the only solution on the market that enables mobile developers to monetize pirated copies of their apps through advertising. Established in 2015, we are a remote company with headquarters in the Netherlands. Currently we serve over 150 million ad requests daily (and counting!).
Purified — Purified is a nutritional supplement supplier.. It offers black chocolate produced by the best doctors in collaboration with scientists.
Elmo — In our mobility-focused operations, we wanted to optimize business and decrease environmental impact, so we created remote control technology to deliver cars.

Imprimatur Capital Fund Management is a venture capital firm focusing on high-technology at an early stage in its commercial development. We invest in start-up technology businesses which are based on innovative intellectual property, are led by strong teams and have high international growth potential.Imprimatur Capital Fund Management, based inLatvia, manages seed and start-up funds with investors including the Latvian Guarantee Agency, other institutional investors and some private investors. The company source investment opportunities primarily from the Baltic/Nordic/Russia region.Imprimatur Capital Fund Management is a partner firm of Imprimatur Capital Ltd, headquartered in London and with investment operations in Europe, Russia, Asia Pacific, Latin America and the US.

Investment focus

Software, Information Technology, Apps
Seed, Debt Financing, Funding Round
Latvia, United States, United Kingdom

Portfolio highlights

Axial3D — Leading the way with the latest 3D imaging, models, and devices
afriQloud — AfriQloud provides a white-labeled cloud computing solution to telecom operators, internet service providers, system integrators, and managed information technology service providers.
Sonarworks — SoundID Reference software calibrates your speakers and studio headphones, so you can trust that every mix will translate.

ZGI Capital is the fund management company that manages "ZGI fund”, that was founded to support entrepreneurs lacking start-up capital for their business. The total amount of assets available for venture capital investments is of EUR 7.4M. Combined with bank financing, this will allow to finance investment projects with total assets of up toEUR 30M. The fund acts on behalf of various investors including the State.

Investment focus

Manufacturing, Machinery Manufacturing, Consulting
Funding Round, Seed, Debt Financing
Latvia, Estonia

Portfolio highlights

eAgronom — We enable companies to achieve their sustainability goals while supporting farmers in generating additional revenue, improving soil quality, and accessing better financing.
KOOL Latvija — "KOOL Latvija" is a new concept gas station created in Latvia, which at the same time is also a convenient fast shopping place.
Bioreactors.net — Biotechnical center is an innovative company and we provide solutions for industrial biotechnology processes, bioreactor manufacturing and industrial automation. We manufacture bioreactors for laboratory, pilot and industrial scale.

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Investment focus

Biotechnology, Health Care, Software
Seed, Convertible Note, Pre-Seed
United States, India, United Kingdom

Portfolio highlights

MixRift — MIXRIFT - game developers specialized in Mixed Reality
unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.

We are Abingworth, a trans-atlantic bio-science investment firm with a deep understanding of both the science and markets we invest in.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series B, Series A, Series C
United States, United Kingdom, France

Portfolio highlights

Wugen — Oncology Evolved Engineering the Next Generation of Off-the-Shelf Cell Therapies learn about WU-CART PIPELINE learn more PRE-CLINICAL CLINICAL CAR-T (Allogeneic) T-ALL/LBL T-NHL AML Autoimmune LATEST NEWS learn more Wugen Announces Dosing of First Patients in Pivotal Trial of Off-the-Shelf, Allogeneic, CD7-Targeted CAR-T Cell Therapy WU-CART-007 Previously reported Phase 1/2 data on WU-CART-007 demonstrated clinically manageable...
AdvanCell — AdvanCell is a vertically integrated, clinical-stage radiopharmaceutical company developing an innovative pipeline of targeted alpha therapies.
Glycomine — We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.

Qiming Venture Partners USA, founded in 2017, is a healthcare venture capital firm and healthcare investor with deep technical expertise that allows them to identify tomorrow's innovations early and strong operational experience with a hands-on approach that makes us the investor of choice for early-stage biotech companies.Because of theirproven, hands-on approach to supporting CEOs and scaling operations, its partners are frequently sought after to serve on company boards. They are respected business and thought leaders.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series A, Series B, Post-IPO Equity
United States, Canada, China

Portfolio highlights

Icosavax — Icosavax is a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines against infectious diseases, with an initial focus on life-threatening respiratory diseases. Icosavax’s VLP platform technology is designed to enable multivalent, particle-based display of complex viral antigens, whichit believes will induce broad, robust, and durable protection against the specific viruses targeted. Icosavax’s pipeline includes vaccine candidates targeting respiratory syncytial virus (RSV), human metapneumovirus (hMPV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Icosavax was formed in 2017 to advance the breakthrough VLP technology from the Institute for Protein Design at the University of Washington with the goal to discover, develop, and commercialize vaccines against infectious diseases.
Renasant Bio — Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments.
Element Science — Now enrolling patients that are at high risk for sudden cardiac arrest.

We are the corporate venture fund of Roche, a global leader in bringing medicines and in vitro diagnostics to the benefit of patients.

Investment focus

Biotechnology, Health Care, Therapeutics
Series B, Series A, Series C
United States, United Kingdom, Spain

Portfolio highlights

DiogenX — Welcome to DiogenX. Explore our pioneering research and innovative therapies aimed at transforming diabetes treatment
Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
MISSION Therapeutics — Deubiquitylating enzymes: multiple drug opportunities across therapeutic areas

Founded in 2010, TSVC (formerly TEEC Angel Fund) is proud to be a leading early-stage venture capital fund in Silicon Valley.

Investment focus

Software, Artificial Intelligence, Health Care
Seed, Funding Round, Series A
United States, China, Canada

Portfolio highlights

Lumotive — Lumotive is a Seattle-based startup company developing high performance, solid-state lidar for autonomous systems in the automotive, UAV, robotics and related industries. The company's revolutionary beam-steering technology leverages Liquid Crystal Metasurfaces (or LCMs) implemented in mature semiconductor manufacturing processes to deliversmall, inexpensive 3D perception systems with unprecedented performance and reliability. For more information, visit us at www.lumotive.com.
Petal Surgical — Petal is a surgical technology company pioneering incisionless surgery through Acoustic Sculpting, a proprietary form of boiling histotripsy. Our platform uses focused sound waves to precisely destroy harmful tissue without cuts, heat, or toxicity offering gentler alternative to traditional surgery.
Carbon Free Energy Cloud — Carbon Credits Simplified

We are an alternative investment manager working on behalf of the world's preeminent institutions. Discover our work, teams, careers and more.

Investment focus

Information Technology, Biotechnology, Health Care
Private Equity, Series A, Series C
United States, India, Latvia

Portfolio highlights

Quant — Quant is a premier quantitative research and investment fund led by engineering, mathematics, and business students at the University of Illinois Urbana-Champaign. We employ state-of-the-art analysis tools like deep learning and natural language processing to gain an edge on financial markets across the globe.
Yellowbrick Data — Yellowbrick is a SQL data platform built on Kubernetes for enterprise data warehousing, ad-hoc and streaming analytics, AI and BI workloads. Yellowbrick offers unparalleled speed and scalability with minimal infrastructure, deployable across public and private clouds, data centers, laptops and the edge; providing a private data cloud experience that ensures data stays under your control to meet residency and sovereignty needs.
Texas Stock Exchange — The Texas Stock Exchange will focus on enabling U.S. and global companies to access U.S. equity capital markets and will provide a venue to trade and list public companies and the growing universe of exchange-traded products. TXSE will be a fully electronic, national securities exchange that will seek registration with the U.S. Securities and Exchange Commission.

Alexandria Venture Investments is a venture capital firm that develops work in real estate technology, and healthcare sectors. The company's strategic venture capital platform is Alexandria Venture Investments. Since its inception in 1996, the company has invested in disruptive life science, agrifood tech, and technology companies that aredeveloping transformative new modalities and platforms to meaningfully improve human health.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Series C
United States, Canada, France

Portfolio highlights

Tr1x — Tr1x develops cellular therapies intended for the treatment of autoimmune disorders.
Affinia Therapeutics — Affinia Therapeutics is expanding what's possible in adeno-associated virus (AAV) gene therapy today and bringing transformative medicines for people.
Accipiter Biosciences — Accipiter Biosciences is a biotechnology company.

Investors by industry

Community

Artificial intelligence